These results agree well with those recently reported by17, who retrospectively compared serum levels of CHI3L1 in hospitalized COVID-19 patients, healthy subjects, patients with chronic obstructive pulmonary disease and with unrelated interstitial lung disease. This evidence concerns the gene CHI3L1 and COVID-19.